INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation – FMC

NEW YORK CITY, NY / ACCESS Newswire / February 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation ("FMC" or the "Company") (NYSE:FMC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether FMC and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On February 4, 2026, FMC issued a press release "announcing its 2026 priorities and the authorization by the Board to explore strategic options[,]" "including but not limited to[] the sale of the company[.]" In the press release, FMC also announced that "full year revenue guidance is $3.60 billion to $3.80 billion, a decline of 5 percent at the midpoint versus prior year" and that "adjusted EBITDA is expected to be $670 million to $730 million, a decline of 17 percent versus prior year mainly due to lower price."

On this news, FMC’s stock price fell $3.32 per share, or 19.54%, to close at $13.67 per share on February 5, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

SOURCE: Pomerantz LLP

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_474234017/2457/2026-02-25T19:00:29

Scroll to Top